|
End-of-day quote
Pakistan S.E.
23/10/2026
|
5-day change | 1st Jan Change | ||
| 309.23 PKR | -0.32% |
|
-0.84% | -20.67% |
Stock exchange
Pakistan S.E.
GLAXO 309.23 ₨
-0.32%
2.51Cr
₨
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLAXO | 309.23PKR | -0.32% | 2.51Cr ₨ |
Quotes 5-day view: GlaxoSmithKline Pakistan Limited
End-of-day quote Pakistan S.E.| 19/10/2026 | 20/10/2026 | 21/10/2026 | 22/10/2026 | Today | |
|---|---|---|---|---|---|
| Last | PKR 313.98 | PKR 315.05 | PKR 313.52 | PKR 310.22 | PKR 309.23 |
| Volume | 1,13,894 | 1,10,036 | 22,770 | 31,679 | 81,086 |
| Change | +0.49% | +0.34% | -0.49% | -1.05% | -0.32% |
| Opening | PKR 312.50 | PKR 314.00 | PKR 315.05 | PKR 313.50 | PKR 310.00 |
| High | PKR 316.00 | PKR 316.00 | PKR 316.48 | PKR 313.50 | PKR 313.90 |
| Low | PKR 310.05 | PKR 313.50 | PKR 313.00 | PKR 309.80 | PKR 307.00 |
Performance
| 1 day | -0.32% | ||
| 1 week | -0.84% | ||
| Current month | -1.19% | ||
| 1 month | -4.14% | ||
| 3 months | -11.44% | ||
| 6 months | -20.13% | ||
| Current year | -20.67% | ||
| 1 year | -26.25% | ||
| 3 years | +295.89% | ||
| 5 years | +108.93% | ||
| 10 years | +43.16% |
Volumes
marketsDaily volume
81,086
Avg. Volume 20 sessions
71,367
Avg. Volume 20 sessions PKR
2,20,68,817.41
Avg. Volume 20 sessions USD
79,822.91
Record volume 1
1,31,04,330
Record volume 2
47,38,800
Record volume 3
46,52,400
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (PKR)
98,75,20,78,034
Market Cap (USD)
35,70,08,344
Net sales (PKR)
65,90,09,01,000
Net sales (USD)
23,82,44,825
Number of employees
1,606
Sales / Employee (PKR)
4,10,34,185
Sales / Employee (USD)
1,48,347
Free-Float
16.89%
Free-Float capitalization (PKR)
16,67,60,24,579
Free-Float capitalization (USD)
6,02,87,136
Average Daily Capital Traded
0.02%
Indicators
Moving average 5 days
312.4
Moving average 20 days
312.9
Moving average 50 days
320.62
Moving average 100 days
339.79
Price spread / (MMA5)
+1.03%
Price spread / (MMA20)
+1.19%
Price spread / (MMA50)
+3.68%
Price spread / (MMA100)
+9.88%
RSI 9 days
37.77
RSI 14 days
39.82
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | -0.84% | -26.25% | +295.89% | 36Cr | |
| -3.36% | +0.30% | +53.56% | +118.64% | 1,16500Cr | |
| -1.51% | +2.99% | +36.74% | +73.85% | 64TCr | |
| +0.02% | +0.08% | +25.15% | +97.37% | 50TCr | |
| -0.31% | +3.09% | +43.92% | +64.55% | 38TCr | |
| -1.51% | -0.92% | +65.86% | +39.91% | 36TCr | |
| -0.68% | +2.65% | +22.46% | +51.48% | 30TCr | |
| -1.20% | +3.04% | +2.62% | +26.97% | 27TCr | |
| -1.54% | +1.79% | +50.31% | +61.22% | 24TCr | |
| -0.27% | +0.31% | +29.76% | +102.00% | 19TCr | |
| Average | -1.08% | +2.14% | +30.42% | +93.19% | 40.56TCr | |
| Weighted average by Cap. | -1.60% | +3.17% | +40.55% | +81.61% |
Historical Quotes: GlaxoSmithKline Pakistan Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 307 |  | 316.48 |
| 1 month | 305 | | 323 |
| Current year | 293.09 | | 459.27 |
| 1 year | 293.09 | | 459.27 |
| 3 years | 74 | | 481 |
| 5 years | 68 | | 481 |
| 10 years | 68 | | 481 |
Monthly variations
Annual variations
| 2026 | -20.67% | ||
| 2025 | -1.80% | ||
| 2024 | +378.26% | ||
| 2023 | -5.45% | ||
| 2022 | -35.70% | ||
| 2021 | -28.84% | ||
| 2020 | +19.47% | ||
| 2019 | +42.50% | ||
| 2018 | -32.88% | ||
| 2017 | -27.64% | ||
| 2016 | +5.44% | ||
| 2015 | +0.32% | ||
| 2014 | +77.11% | ||
| 2013 | +104.32% | ||
| 2012 | +20.25% | ||
| 2011 | -12.53% | ||
| 2010 | -19.29% | ||
| 2009 | +43.89% | ||
| 2008 | -60.53% | ||
| 2007 | +52.36% | ||
| 2006 | +5.94% | ||
| 2005 | +28.63% | ||
| 2004 | -5.26% | ||
| 2003 | +225.19% | ||
| 2002 | +12.80% | ||
| 2001 | -16.20% | ||
| 2000 | +70.48% | ||
| 1999 | +16.67% | ||
| 1998 | -15.09% | ||
| 1997 | -26.39% | ||
| 1996 | -41.94% | ||
| 1995 | -27.06% | ||
| 1994 | -10.29% | ||
| 1993 | +43.56% | ||
| 1992 | +1.93% |
- Stock Market
- Stocks
- GLAXO Stock
- Quotes GlaxoSmithKline Pakistan Limited
Select your edition
All financial news and data tailored to specific country editions
